About CVS
Overview
CVS, operating under the official domain cm-sc.com, is a financial institution based in Hong Kong, founded on 12 February 2020. According to its own description, it provides Investment Banking and Securities Finance services through its China Vered Securities platform. However, independent public information about the broker is extremely limited, making it difficult to verify its claims or assess its operations.
Our review could not locate any official website content beyond the basic description, and no user reviews or independent analyses are available. The lack of publicly accessible information is a notable concern for any prospective client seeking to evaluate the firm's credibility and services.
Regulation and Licensing
CVS states that it is a regulated financial institution, but our records show no active regulators on file for this entity. The absence of verifiable regulatory oversight is a serious red flag for potential investors. In Hong Kong, financial firms offering securities services are typically required to be licensed by the Securities and Futures Commission (SFC), but no such licence could be confirmed for CVS.
We cross-checked the provided address (24/F, China Taiping Tower, 8 Sunning Road, Causeway Bay) against public records, but this does not guarantee legitimacy. Without regulatory confirmation, clients have no recourse through a recognised ombudsman or compensation scheme, increasing the risk of dealing with this broker.
Company Background
Founded in 2020, CVS (China Vered Securities) operates from an office in Causeway Bay, Hong Kong. The firm's description mentions Investment Banking and Securities Finance, suggesting a focus on institutional or corporate clients rather than retail traders. However, no detailed information about its team, parent company, or operational history is available in the public domain.
The broker's unique selling points or differentiation from other securities firms remain unclear. The lack of an accessible website or marketing materials hinders any meaningful assessment of its capabilities or track record. Potential clients should exercise extreme caution when considering services from an entity with such limited transparency.
Risk Assessment
FXCanary's Scam Risk Score for CVS is 75 out of 100, categorised as 'Severe'. This high score reflects the combination of no confirmed regulation, extremely limited public information, and no independent user feedback. The broker's claims of being regulated cannot be substantiated, and the absence of any verifiable licence places it firmly in the high-risk category.
Traders and investors should be aware that dealing with an unregulated entity in the securities space carries substantial risks, including potential fraud, lack of dispute resolution, and loss of funds. We strongly advise against committing any capital until the broker provides clear and verifiable regulatory evidence.
Overview compiled by FXCanary from regulatory records and public data. full CVS review